Organogenesis Holdings (ORGO) Interest Coverage Ratio Growth (3y) (2020 - 2026)
Organogenesis Holdings (ORGO) Interest Coverage Ratio Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 4.39% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 74.02% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 42.49% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -3.66% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 121.93% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn | 215.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 215.51% |
| Dec 31, 2025 | 25.41% |
| Sep 30, 2025 | -162.36% |
| Jun 30, 2025 | 4.76% |
| Mar 31, 2025 | 445.41% |
| Dec 31, 2024 | -109.80% |
| Sep 30, 2024 | 6.49% |
| Jun 30, 2024 | -62.73% |
| Mar 31, 2024 | -51.35% |
| Dec 31, 2023 | -32.73% |
| Sep 30, 2023 | 33.15% |
| Jun 30, 2023 | 185.27% |
| Mar 31, 2023 | -0.85% |
| Dec 31, 2022 | -606.16% |
| Sep 30, 2022 | 42.82% |
| Jun 30, 2022 | 90.24% |
| Mar 31, 2022 | 70.58% |
| Dec 31, 2021 | 150.74% |
| Sep 30, 2021 | 73.29% |
| Jun 30, 2021 | 53.05% |